Publication | Closed Access

Treatment With Solifenacin Increases Warning Time and Improves Symptoms of Overactive Bladder: Results From VENUS, a Randomized, Double-Blind, Placebo-Controlled Trial

UrologyVoiding DysfunctionImproves SymptomsGeriatric UrologyFemale UrologyPlacebo-controlled TrialPain ManagementPharmacotherapyOveractive BladderMedicineAnesthesiology